Target intelligence / Profile preview

Gamma Aminobutyric Acid Transaminase (None)

Target
None
Molecular classification
Enzyme, Transferase, Transaminase
01

Overview

Gamma aminobutyric acid transaminase (GABA-T) is a pyridoxal 5'-phosphate-dependent enzyme that catalyzes the degradation of GABA, the primary inhibitory neurotransmitter in the mammalian central nervous system. It converts GABA and 2-oxoglutarate into succinic semialdehyde and L-glutamate. GABA-T is a validated target for antiepileptic drugs such as vigabatrin, which inhibits the enzyme to increase GABA levels in the brain. Deficiency of GABA-T due to mutations in the ABAT gene results in a severe neurological disorder.

Other names
4-Aminobutyrate transaminaseABAT
02

Mechanism of action

Irreversible inhibition of GABA-T, leading to increased GABA levels in the brain.

03

Biological functions

GABA catabolismRegulation of neurotransmitter levelsNeurotransmissionAmino acid metabolism
04

Disease associations

GABA-transaminase deficiencyEpilepsyNeurological disorders
05

Safety considerations

Visual field defects associated with vigabatrin use.
06

Interacting drugs

Vigabatrin
07

Biomarkers

GABA levels in cerebrospinal fluidBeta-alanine levels

Beyond the preview

Go deeper on Gamma Aminobutyric Acid Transaminase (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma Aminobutyric Acid Transaminase (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call